These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


52 related items for PubMed ID: 20972944

  • 21. Long-term biochemical results after operative treatment of primary hyperparathyroidism associated with multiple endocrine neoplasia types I and IIa: is a more or less extended operation essential?
    Dotzenrath C, Cupisti K, Goretzki PE, Yang Q, Simon D, Ohmann C, Röher HD.
    Eur J Surg; 2001 Mar; 167(3):173-8. PubMed ID: 11316400
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Primary hyperparathyroidism and familial hyperparathyroid syndromes.
    Blackburn M, Diamond T.
    Aust Fam Physician; 2007 Dec; 36(12):1029-33. PubMed ID: 18075629
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Attitudes and preferences in patients with acromegaly on long-term treatment with somatostatin analogues.
    Follin C, Karlsson S.
    Endocr Connect; 2016 Jul; 5(4):167-73. PubMed ID: 27458240
    [Abstract] [Full Text] [Related]

  • 29. [Medical treatment of primary hyperparathyroidism].
    Inoue D.
    Nihon Rinsho; 2011 Mar; 69 Suppl 2():449-54. PubMed ID: 21830583
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Somatostatin analogues do not affect calcium metabolism in patients with acromegaly and primary hyperparathyroidism [corrected] due to MEN 1-like syndrome.
    Bogazzi F, Lombardi M, Russo D, Sardella C, Raggi F, Brogioni S, Cetani F, Ceccarelli C, Mariani G, Basolo F, Martino E.
    Horm Metab Res; 2011 Feb; 43(2):126-9. PubMed ID: 20972944
    [Abstract] [Full Text] [Related]

  • 33. Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism (PHP) in multiple endocrine neoplasia type 1 (MEN1) patients.
    Faggiano A, Tavares LB, Tauchmanova L, Milone F, Mansueto G, Ramundo V, De Caro ML, Lombardi G, De Rosa G, Colao A.
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):756-62. PubMed ID: 18485119
    [Abstract] [Full Text] [Related]

  • 34. A patient with MEN1-associated hyperparathyroidism, responsive to cinacalcet.
    Falchetti A, Cilotti A, Vaggelli L, Masi L, Amedei A, Cioppi F, Tonelli F, Brandi ML.
    Nat Clin Pract Endocrinol Metab; 2008 Jun; 4(6):351-7. PubMed ID: 18414463
    [Abstract] [Full Text] [Related]

  • 35. Primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1: comparison with sporadic parathyroid adenomas.
    Katai M, Sakurai A, Ikeo Y, Hashizume K.
    Horm Metab Res; 2001 Aug; 33(8):499-503. PubMed ID: 11544565
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Somatostatin analogues do not affect calcium metabolism in patients with acromegaly and primary hyperparathyroidism [corrected] due to MEN 1-like syndrome.
    Bogazzi F, Lombardi M, Russo D, Sardella C, Raggi F, Brogioni S, Cetani F, Ceccarelli C, Mariani G, Basolo F, Martino E.
    Horm Metab Res; 2011 Feb; 43(2):126-9. PubMed ID: 20972944
    [Abstract] [Full Text] [Related]

  • 38. Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism (PHP) in multiple endocrine neoplasia type 1 (MEN1) patients.
    Faggiano A, Tavares LB, Tauchmanova L, Milone F, Mansueto G, Ramundo V, De Caro ML, Lombardi G, De Rosa G, Colao A.
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):756-62. PubMed ID: 18485119
    [Abstract] [Full Text] [Related]

  • 39. A patient with MEN1-associated hyperparathyroidism, responsive to cinacalcet.
    Falchetti A, Cilotti A, Vaggelli L, Masi L, Amedei A, Cioppi F, Tonelli F, Brandi ML.
    Nat Clin Pract Endocrinol Metab; 2008 Jun; 4(6):351-7. PubMed ID: 18414463
    [Abstract] [Full Text] [Related]

  • 40. Primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1: comparison with sporadic parathyroid adenomas.
    Katai M, Sakurai A, Ikeo Y, Hashizume K.
    Horm Metab Res; 2001 Aug; 33(8):499-503. PubMed ID: 11544565
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 3.